One US state is found to have Alzheimer’s ‘hot spots.’ What it reveals about America’s health care - Alzheimer’s disease ...

Tantalizing results from small trials and anecdotes raised hopes that drugs like Ozempic could help. Despite setbacks, ...

The outlook for dementia care is changing fast. UC experts explain what that means for patients and families, and what it ...

Where you live in Maryland will likely affect your quality of care if you are diagnosed with Alzheimer’s disease, according ...

A new study reveals that obesity accelerated Alzheimer's blood biomarkers by 95% over five years, highlighting a strong ...

NEW JERSEY -- U.S. Sen. Andy Kim of New Jersey is opening up about his father's Alzheimer's diagnosis and his journey to ...

High-sensitivity C-reactive protein (CRP) decreased significantly in the semaglutide group, with estimated treatment ratios ...

GLP-1 drugs, which include Ozempic and Wegovy, have become one of the most closely watched experimental approaches for ...

Major Alzheimer’s breakthroughs in 2025 include new FDA-approved blood tests, at-home treatments, and lifestyle research showing cognitive benefits for older adults.

UD's DementiaBank outshines global competitors, driving machine-learning advances in early dementia prediction ...

Mean amyloid levels remained below 24.1 centiloids at 3 years for participants who completed donanemab treatment by 1 year.

Details from two large trials of Novo Nordisk's GLP-1 drug semaglutide showed it provided no cognitive benefit for people ...